The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiopulmonary Autotransfusion Devices Market Research Report 2025
Synopsis
Autotransfusion is also known as intraoperative blood salvage. It is a process in which blood is collected from active bleeding site of patient and rein fused into the same patient during cardiac surgery. Several commercial autotransfusion devices are available in market. There are three types of autotransfusion system namely; continuous flow centrifugal system, discontinuous flow centrifugal system and unwashed blood filter system. The unwashed blood filter system for autotransfusion is more popular than other systems because it is inexpensive system and easy to use. This technology had led to increased use of centrifugation devices for blood collection. During cardiopulmonary bypass (CPB) blood is collected from patient active bleeding site by the help of suckers in different ways. This blood is collected in cardiotomy reservoir and it is filtered in this reservoir. Then this blood is redirected to venous reservoir where it is oxygenated and finally it is returned to patient body.
The global Cardiopulmonary Autotransfusion Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion Devices.
Report Scope
The Cardiopulmonary Autotransfusion Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiopulmonary Autotransfusion Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Stryker
Atrium Medical
Segment by Type
On-Pump Transfusion Device
Off-Pump Transfusion Device
Segment by Application
Hospitals
Ambulatory Surgical Center
Cardiac Research Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Autotransfusion is also known as intraoperative blood salvage. It is a process in which blood is collected from active bleeding site of patient and rein fused into the same patient during cardiac surgery. Several commercial autotransfusion devices are available in market. There are three types of autotransfusion system namely; continuous flow centrifugal system, discontinuous flow centrifugal system and unwashed blood filter system. The unwashed blood filter system for autotransfusion is more popular than other systems because it is inexpensive system and easy to use. This technology had led to increased use of centrifugation devices for blood collection. During cardiopulmonary bypass (CPB) blood is collected from patient active bleeding site by the help of suckers in different ways. This blood is collected in cardiotomy reservoir and it is filtered in this reservoir. Then this blood is redirected to venous reservoir where it is oxygenated and finally it is returned to patient body.
The global Cardiopulmonary Autotransfusion Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion Devices.
Report Scope
The Cardiopulmonary Autotransfusion Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiopulmonary Autotransfusion Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Stryker
Atrium Medical
Segment by Type
On-Pump Transfusion Device
Off-Pump Transfusion Device
Segment by Application
Hospitals
Ambulatory Surgical Center
Cardiac Research Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cardiopulmonary Autotransfusion Devices Market Overview
1.1 Product Overview and Scope of Cardiopulmonary Autotransfusion Devices
1.2 Cardiopulmonary Autotransfusion Devices Segment by Type
1.2.1 Global Cardiopulmonary Autotransfusion Devices Market Value Comparison by Type (2024-2030)
1.2.2 On-Pump Transfusion Device
1.2.3 Off-Pump Transfusion Device
1.3 Cardiopulmonary Autotransfusion Devices Segment by Application
1.3.1 Global Cardiopulmonary Autotransfusion Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Cardiac Research Centers
1.4 Global Cardiopulmonary Autotransfusion Devices Market Size Estimates and Forecasts
1.4.1 Global Cardiopulmonary Autotransfusion Devices Revenue 2019-2030
1.4.2 Global Cardiopulmonary Autotransfusion Devices Sales 2019-2030
1.4.3 Global Cardiopulmonary Autotransfusion Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cardiopulmonary Autotransfusion Devices Market Competition by Manufacturers
2.1 Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cardiopulmonary Autotransfusion Devices Average Price by Manufacturers (2019-2024)
2.4 Global Cardiopulmonary Autotransfusion Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiopulmonary Autotransfusion Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion Devices, Product Type & Application
2.7 Cardiopulmonary Autotransfusion Devices Market Competitive Situation and Trends
2.7.1 Cardiopulmonary Autotransfusion Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiopulmonary Autotransfusion Devices Players Market Share by Revenue
2.7.3 Global Cardiopulmonary Autotransfusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiopulmonary Autotransfusion Devices Retrospective Market Scenario by Region
3.1 Global Cardiopulmonary Autotransfusion Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cardiopulmonary Autotransfusion Devices Global Cardiopulmonary Autotransfusion Devices Sales by Region: 2019-2030
3.2.1 Global Cardiopulmonary Autotransfusion Devices Sales by Region: 2019-2024
3.2.2 Global Cardiopulmonary Autotransfusion Devices Sales by Region: 2025-2030
3.3 Global Cardiopulmonary Autotransfusion Devices Global Cardiopulmonary Autotransfusion Devices Revenue by Region: 2019-2030
3.3.1 Global Cardiopulmonary Autotransfusion Devices Revenue by Region: 2019-2024
3.3.2 Global Cardiopulmonary Autotransfusion Devices Revenue by Region: 2025-2030
3.4 North America Cardiopulmonary Autotransfusion Devices Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Autotransfusion Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2030)
3.4.3 North America Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Autotransfusion Devices Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Autotransfusion Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2030)
3.5.3 Europe Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiopulmonary Autotransfusion Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiopulmonary Autotransfusion Devices Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Autotransfusion Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2030)
3.7.3 Latin America Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Autotransfusion Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Autotransfusion Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cardiopulmonary Autotransfusion Devices Sales by Type (2019-2030)
4.1.1 Global Cardiopulmonary Autotransfusion Devices Sales by Type (2019-2024)
4.1.2 Global Cardiopulmonary Autotransfusion Devices Sales by Type (2025-2030)
4.1.3 Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Type (2019-2030)
4.2 Global Cardiopulmonary Autotransfusion Devices Revenue by Type (2019-2030)
4.2.1 Global Cardiopulmonary Autotransfusion Devices Revenue by Type (2019-2024)
4.2.2 Global Cardiopulmonary Autotransfusion Devices Revenue by Type (2025-2030)
4.2.3 Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Type (2019-2030)
4.3 Global Cardiopulmonary Autotransfusion Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cardiopulmonary Autotransfusion Devices Sales by Application (2019-2030)
5.1.1 Global Cardiopulmonary Autotransfusion Devices Sales by Application (2019-2024)
5.1.2 Global Cardiopulmonary Autotransfusion Devices Sales by Application (2025-2030)
5.1.3 Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Application (2019-2030)
5.2 Global Cardiopulmonary Autotransfusion Devices Revenue by Application (2019-2030)
5.2.1 Global Cardiopulmonary Autotransfusion Devices Revenue by Application (2019-2024)
5.2.2 Global Cardiopulmonary Autotransfusion Devices Revenue by Application (2025-2030)
5.2.3 Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Application (2019-2030)
5.3 Global Cardiopulmonary Autotransfusion Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Corporation Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Fresenius Kabi Cardiopulmonary Autotransfusion Devices Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Haemonetics
6.2.1 Haemonetics Corporation Information
6.2.2 Haemonetics Description and Business Overview
6.2.3 Haemonetics Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Haemonetics Cardiopulmonary Autotransfusion Devices Product Portfolio
6.2.5 Haemonetics Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Corporation Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LivaNova Cardiopulmonary Autotransfusion Devices Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Cardiopulmonary Autotransfusion Devices Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Cardiopulmonary Autotransfusion Devices Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Stryker Cardiopulmonary Autotransfusion Devices Product Portfolio
6.6.5 Stryker Recent Developments/Updates
6.7 Atrium Medical
6.6.1 Atrium Medical Corporation Information
6.6.2 Atrium Medical Description and Business Overview
6.6.3 Atrium Medical Cardiopulmonary Autotransfusion Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Atrium Medical Cardiopulmonary Autotransfusion Devices Product Portfolio
6.7.5 Atrium Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Autotransfusion Devices Industry Chain Analysis
7.2 Cardiopulmonary Autotransfusion Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Autotransfusion Devices Production Mode & Process
7.4 Cardiopulmonary Autotransfusion Devices Sales and Marketing
7.4.1 Cardiopulmonary Autotransfusion Devices Sales Channels
7.4.2 Cardiopulmonary Autotransfusion Devices Distributors
7.5 Cardiopulmonary Autotransfusion Devices Customers
8 Cardiopulmonary Autotransfusion Devices Market Dynamics
8.1 Cardiopulmonary Autotransfusion Devices Industry Trends
8.2 Cardiopulmonary Autotransfusion Devices Market Drivers
8.3 Cardiopulmonary Autotransfusion Devices Market Challenges
8.4 Cardiopulmonary Autotransfusion Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cardiopulmonary Autotransfusion Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cardiopulmonary Autotransfusion Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Cardiopulmonary Autotransfusion Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cardiopulmonary Autotransfusion Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cardiopulmonary Autotransfusion Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cardiopulmonary Autotransfusion Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cardiopulmonary Autotransfusion Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cardiopulmonary Autotransfusion Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cardiopulmonary Autotransfusion Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cardiopulmonary Autotransfusion Devices, Product Type & Application
Table 12. Global Key Manufacturers of Cardiopulmonary Autotransfusion Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cardiopulmonary Autotransfusion Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cardiopulmonary Autotransfusion Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cardiopulmonary Autotransfusion Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Region (2019-2024)
Table 19. Global Cardiopulmonary Autotransfusion Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Region (2025-2030)
Table 21. Global Cardiopulmonary Autotransfusion Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Cardiopulmonary Autotransfusion Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Cardiopulmonary Autotransfusion Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Cardiopulmonary Autotransfusion Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cardiopulmonary Autotransfusion Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cardiopulmonary Autotransfusion Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Cardiopulmonary Autotransfusion Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cardiopulmonary Autotransfusion Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cardiopulmonary Autotransfusion Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cardiopulmonary Autotransfusion Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Cardiopulmonary Autotransfusion Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Cardiopulmonary Autotransfusion Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cardiopulmonary Autotransfusion Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cardiopulmonary Autotransfusion Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Cardiopulmonary Autotransfusion Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cardiopulmonary Autotransfusion Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cardiopulmonary Autotransfusion Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Cardiopulmonary Autotransfusion Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Cardiopulmonary Autotransfusion Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Cardiopulmonary Autotransfusion Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cardiopulmonary Autotransfusion Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cardiopulmonary Autotransfusion Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Cardiopulmonary Autotransfusion Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Type (2019-2024)
Table 53. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Type (2025-2030)
Table 54. Global Cardiopulmonary Autotransfusion Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cardiopulmonary Autotransfusion Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Cardiopulmonary Autotransfusion Devices Price (USD/Unit) by Type (2019-2024)
Table 59. Global Cardiopulmonary Autotransfusion Devices Price (USD/Unit) by Type (2025-2030)
Table 60. Global Cardiopulmonary Autotransfusion Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Cardiopulmonary Autotransfusion Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Application (2019-2024)
Table 63. Global Cardiopulmonary Autotransfusion Devices Sales Market Share by Application (2025-2030)
Table 64. Global Cardiopulmonary Autotransfusion Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cardiopulmonary Autotransfusion Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Cardiopulmonary Autotransfusion Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Cardiopulmonary Autotransfusion Devices Price (USD/Unit) by Application (2019-2024)
Table 69. Global Cardiopulmonary Autotransfusion Devices Price (USD/Unit) by Application (2025-2030)
Table 70. Fresenius Kabi Corporation Information
Table 71. Fresenius Kabi Description and Business Overview
Table 72. Fresenius Kabi Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Fresenius Kabi Cardiopulmonary Autotransfusion Devices Product
Table 74. Fresenius Kabi Recent Developments/Updates
Table 75. Haemonetics Corporation Information
Table 76. Haemonetics Description and Business Overview
Table 77. Haemonetics Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Haemonetics Cardiopulmonary Autotransfusion Devices Product
Table 79. Haemonetics Recent Developments/Updates
Table 80. LivaNova Corporation Information
Table 81. LivaNova Description and Business Overview
Table 82. LivaNova Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. LivaNova Cardiopulmonary Autotransfusion Devices Product
Table 84. LivaNova Recent Developments/Updates
Table 85. Medtronic Corporation Information
Table 86. Medtronic Description and Business Overview
Table 87. Medtronic Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Medtronic Cardiopulmonary Autotransfusion Devices Product
Table 89. Medtronic Recent Developments/Updates
Table 90. Terumo Corporation Information
Table 91. Terumo Description and Business Overview
Table 92. Terumo Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Terumo Cardiopulmonary Autotransfusion Devices Product
Table 94. Terumo Recent Developments/Updates
Table 95. Stryker Corporation Information
Table 96. Stryker Description and Business Overview
Table 97. Stryker Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Stryker Cardiopulmonary Autotransfusion Devices Product
Table 99. Stryker Recent Developments/Updates
Table 100. Atrium Medical Corporation Information
Table 101. Atrium Medical Description and Business Overview
Table 102. Atrium Medical Cardiopulmonary Autotransfusion Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Atrium Medical Cardiopulmonary Autotransfusion Devices Product
Table 104. Atrium Medical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Cardiopulmonary Autotransfusion Devices Distributors List
Table 108. Cardiopulmonary Autotransfusion Devices Customers List
Table 109. Cardiopulmonary Autotransfusion Devices Market Trends
Table 110. Cardiopulmonary Autotransfusion Devices Market Drivers
Table 111. Cardiopulmonary Autotransfusion Devices Market Challenges
Table 112. Cardiopulmonary Autotransfusion Devices Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cardiopulmonary Autotransfusion Devices
Figure 2. Global Cardiopulmonary Autotransfusion Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cardiopulmonary Autotransfusion Devices Market Share by Type in 2023 & 2030
Figure 4. On-Pump Transfusion Device Product Picture
Figure 5. Off-Pump Transfusion Device Product Picture
Figure 6. Global Cardiopulmonary Autotransfusion Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cardiopulmonary Autotransfusion Devices Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Center
Figure 10. Cardiac Research Centers
Figure 11. Global Cardiopulmonary Autotransfusion Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Cardiopulmonary Autotransfusion Devices Market Size (2019-2030) & (US$ Million)
Figure 13. Global Cardiopulmonary Autotransfusion Devices Sales (2019-2030) & (K Units)
Figure 14. Global Cardiopulmonary Autotransfusion Devices Average Price (USD/Unit) & (2019-2030)
Figure 15. Cardiopulmonary Autotransfusion Devices Report Years Considered
Figure 16. Cardiopulmonary Autotransfusion Devices Sales Share by Manufacturers in 2023
Figure 17. Global Cardiopulmonary Autotransfusion Devices Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Cardiopulmonary Autotransfusion Devices Players: Market Share by Revenue in 2023
Figure 19. Cardiopulmonary Autotransfusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Cardiopulmonary Autotransfusion Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Cardiopulmonary Autotransfusion Devices Sales Market Share by Country (2019-2030)
Figure 22. North America Cardiopulmonary Autotransfusion Devices Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Cardiopulmonary Autotransfusion Devices Sales Market Share by Country (2019-2030)
Figure 26. Europe Cardiopulmonary Autotransfusion Devices Revenue Market Share by Country (2019-2030)
Figure 27. Germany Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Cardiopulmonary Autotransfusion Devices Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Cardiopulmonary Autotransfusion Devices Revenue Market Share by Region (2019-2030)
Figure 34. China Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Cardiopulmonary Autotransfusion Devices Sales Market Share by Country (2019-2030)
Figure 45. Latin America Cardiopulmonary Autotransfusion Devices Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Cardiopulmonary Autotransfusion Devices Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Cardiopulmonary Autotransfusion Devices Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Cardiopulmonary Autotransfusion Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Cardiopulmonary Autotransfusion Devices by Type (2019-2030)
Figure 55. Global Revenue Market Share of Cardiopulmonary Autotransfusion Devices by Type (2019-2030)
Figure 56. Global Cardiopulmonary Autotransfusion Devices Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Cardiopulmonary Autotransfusion Devices by Application (2019-2030)
Figure 58. Global Revenue Market Share of Cardiopulmonary Autotransfusion Devices by Application (2019-2030)
Figure 59. Global Cardiopulmonary Autotransfusion Devices Price (USD/Unit) by Application (2019-2030)
Figure 60. Cardiopulmonary Autotransfusion Devices Value Chain
Figure 61. Cardiopulmonary Autotransfusion Devices Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
